Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

Hospital Nacional de Parapléjicos de Toledo · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
endurance
spinal cord injuries, walking abilities, rimonabant, endurance, incomplete sci, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 884315
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.